Contraindications
Do not administer to dogs weighing less than 2.5 kg.
Do not administer to unweaned puppies and kittens, as such animals are rarely infected with tapeworms.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Special warnings
Fleas serve as intermediate hosts for one common type of tapeworm - Dipylidium caninum. To avoid reinfection with this parasite, flea control of the animal and its housing should be carried out at the same time. Unless flea control is complete an infected flea population may survive, i.e., re-treatment of the animal may be necessary.
Unnecessary use of antiparasitics or use deviating from the instructions given in the SPC may increase the resistance selection pressure and lead to reduced efficacy. The decision to use the product should be based on confirmation of the parasitic species and burden, or of the risk of infection based on its epidemiological features, for each individual animal.
The possibility that other animals in the same household can be a source of reinfection with fleas and tapeworms should be considered, and these should be treated as necessary with an appropriate product.
The use of this product should take into account local information about susceptibility of the target parasites, where available.
As a precautionary measure to prevent the establishment of Echinococcus multilocularis in the UK, it is recommended that all dogs entering the country be treated with praziquantel.
Adverse events
None known.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder, its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Symptoms of overdose (and where applicable, emergency procedures and antidotes)
Not applicable.